Cargando…

Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting

The cytochrome P450 2C9 and vitamin K epoxide reductase complex subunit 1 genotypes are associated with anticoagulation control and the clinical events in warfarin therapy. However, the clinical utility of gene-based warfarin dosing (GBWD) is controversial. We compared the anticoagulation control an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jinhua, Wu, Tingting, Chen, Wenjun, Fu, Jinglan, Xia, Xiaotong, Chen, Liangwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988825/ https://www.ncbi.nlm.nih.gov/pubmed/32038232 http://dx.doi.org/10.3389/fphar.2019.01527

Ejemplares similares

Clinical analysis of the effects of azole antifungal agents on the anticoagulant activity of warfarin
por: Chen, Wenjun, et al.
Publicado: (2020)

Comparison of the outcomes of warfarin therapy and economics by online and offline anticoagulation management models: protocol for a randomised controlled trial
por: Xia, Xiaotong, et al.
Publicado: (2019)

Changes in the Gut Microbiota May Affect the Clinical Efficacy of Oral Anticoagulants
por: Chen, Wenjun, et al.
Publicado: (2022)

Application of a warfarin dosing calculator to guide individualized dosing versus empirical adjustment after fixed dosing: a pilot study
por: Cai, Xiaofang, et al.
Publicado: (2023)

Gene-based anticoagulation regimens for an infant after mitral-valve replacement: A case report
por: Cao, Hua, et al.
Publicado: (2020)

Evaluation of the Effect of Lime Fruit Juice on the Anticoagulant Effect of Warfarin
por: Adepoju, GKA, et al.
Publicado: (2010)

Left atrial appendage thrombus formation in a patient with atrial fibrillation on dabigatran therapy associated with CES1 and ABCB1 genetic polymorphisms: A case report
por: Wu, Tingting, et al.
Publicado: (2020)

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2021)

Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study
por: Claudio-Campos, Karla, et al.
Publicado: (2017)

Effect of Standardized Warfarin Treatment Protocol on Anticoagulant Effect: Comparison of a Warfarin Medication Therapy Adherence Clinic with Usual Medical Care
por: Aidit, Salihah, et al.
Publicado: (2017)

Anticoagulation Quality of Warfarin and the Role of Physician–Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study
por: Qiu, Sha, et al.
Publicado: (2021)

Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2018)

Warfarin anticoagulation management during the COVID-19 pandemic: The role of internet clinic and machine learning
por: Dai, Meng-Fei, et al.
Publicado: (2022)

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
por: Vinogradova, Yana, et al.
Publicado: (2018)

Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
por: Roberti, Roberta, et al.
Publicado: (2021)

PD-1 inhibitor-based adverse events in solid tumors: A retrospective real-world study
por: Huang, Guili, et al.
Publicado: (2022)

Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population
por: Ren, Yirong, et al.
Publicado: (2020)

Evaluation of a Pharmacist-Led Remote Warfarin Management Model Using a Smartphone Application (Yixing) in Improving Patients’ Knowledge and Outcomes of Anticoagulation Therapy
por: Jiang, Shudan, et al.
Publicado: (2021)

Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans
por: Steiner, Heidi E., et al.
Publicado: (2021)

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2017)

Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies
por: Shen, Nan-Nan, et al.
Publicado: (2021)

Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database
por: Peng, Jing, et al.
Publicado: (2022)

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients
por: Tavares, Letícia C., et al.
Publicado: (2018)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
por: Roche-Lima, Abiel, et al.
Publicado: (2020)

Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2020)

Successful treatment discontinuation in CML patients with full-dose and low-dose TKI: Results from real-world practice
por: Chen, Yilin, et al.
Publicado: (2023)

Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
por: Umetsu, Ryogo, et al.
Publicado: (2021)

A Multilevel Analysis of Real-World Variations in Oral Anticoagulation Initiation for Atrial Fibrillation in Valencia, a European Region
por: García-Sempere, Aníbal, et al.
Publicado: (2017)

Non-vitamin K Antagonist Oral Anticoagulants vs. Warfarin at Risk of Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Gu, Zhi-Chun, et al.
Publicado: (2018)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
por: Li, Dongxuan, et al.
Publicado: (2023)

Editorial: The use of real world data for regulatory purposes in the rare diseases setting
por: Giannuzzi, Viviana, et al.
Publicado: (2022)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database – A Case Study
por: Gaio, Mario, et al.
Publicado: (2021)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
por: de Padua Mansur, Antonio, et al.
Publicado: (2012)

Simulating clinical trials for model-informed precision dosing: using warfarin treatment as a use case
por: Augustin, David, et al.
Publicado: (2023)

Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2021)

Physician–Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development
por: Wang, Na, et al.
Publicado: (2021)

Real-world comparison of non-vitamin K antagonist oral anticoagulants and warfarin in Asian octogenarian patients with atrial fibrillation
por: Kwon, Chang Hee, et al.
Publicado: (2016)

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban
por: Lip, Gregory Y. H., et al.
Publicado: (2018)

Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin
por: Pyykönen, Mikko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0k602ekj0qkk0cr6ojivhhodps